In 2018, a 26-month-old girl, fully vaccinated with Rotarix in 2016, presented with fever, diarrhea, and vomiting. A rapid test showed that her feces contained rotavirus A (RVA). VP7 reverse transcription-PCR (RT-PCR) and Illumina sequencing showed that a G1P[8] strain with a Wa-like genotype constellation was the etiologic agent. This is the first near-complete RVA genome sequence from Nigeria. R otavirus A (RVA) belongs to the genus Rotavirus, family Reoviridae. The virus has a double-stranded RNA (dsRNA) genome with 11 segments (1). It is the most important etiologic agent globally of diarrhea in children under 5 years of age (2). Two globally licensed vaccines (Rotarix and RotaTeq) have been developed for the control of human RVA (3). In Nigeria, RVA vaccination is recommended for children as part of the routine immunization program. However, it is currently only available for a fee. Consequently, only those who can afford to pay for the vaccine have it administered to their infants. Here, we describe the first near-complete genome of a wild-type RVA strain from Nigeria from a child who had been previously vaccinated with Rotarix.
All 11 segments showed a range of 98.9% to 99.9% similarity with known contemporary RVA strains (Table 1 ). Precisely 6.2% (48/777) and 5.2% (17/326) of the amino acid residues were different between the VP4 and VP7 proteins of the Nigerian G1P [8] strain reported here and the Rotarix vaccine strain.
We describe here what is, to the best of our knowledge, the first near-complete human RVA genome sequence from Nigeria. This genome will serve as a reference for the region and form part of the baseline data needed to address the outstanding issues of rotavirus vaccine failure in Nigeria and globally (10) .
Data availability. The assembled genomes have been deposited in GenBank under the accession numbers MN304722 to MN304732. The raw reads have been deposited under SRA accession number SRX7053324.
